A company can be many things at the same time: a factory, a subsidiary, a patent portfolio, a piece within a supply chain. But, in the technological war we are seeing between China and Europe, it can also become a battlefield. Nexperia fits right in there. We are not just talking about who owns a semiconductor company based in the Netherlands and owned by the Chinese Wingtech, but about who can decide on it when courts, governments and the fear that certain industrial capabilities end up under another center of power come into play.
The new demand. The latest movement comes from China. According to ReutersWingtech Technology and a subsidiary have filed a lawsuit against Nexperia BV and five other entities before a court in Guangdong, which has already accepted the case. The company provisionally claims 8 billion yuan, about $1.18 billion, for the economic losses it attributes to the conflict. SCMP adds another relevant element: Wingtech is not only asking for compensation, it is also demanding to regain full control over Nexperia, a point that once again places the case in the field of corporate governance.
The origin of the crash. To understand why the demand does not come from nowhere, you have to go back to September 2025. So, The Dutch Government intervened Nexperia and removed Wingtech from effective control of the company, citing fears about a possible transfer of operations and intellectual property to China. The administrative decision was later revoked, but the problem did not go away. Wingtech maintains that its scope of control remained limited by a parallel Dutch court ruling, still relevant to the dispute.
Nexperia’s response. The Netherlands-based firm has responded by downgrading the immediate scope of the judicial move. In statements reported by the aforementioned news agency, Nexperia stated that it “has taken note of Wingtech’s announcement” and that it understands that the corresponding court “has not opened the case to trial.” He also regretted the strategy of its Chinese owner and maintained that Wingtech does not seem interested in reaching a solution beneficial to all parties, including its own shareholders.
The Chinese legal route. The lawsuit is not only based on a business claim, but on a politically charged legal framework. Wingtech invokes China’s Foreign Sanctions Law to seek compensation for damages it attributes to restrictions on Nexperia. The company maintains that Nexperia and its executives applied “discriminatory restrictive measures” within the meaning of that law.
The financial blow. The financial blow. The push for Nexperia is also leaving its mark on Wingtech’s accounts. Reuters notes that the company closed 2025 with a net loss of 8.7 billion yuan, compared to 2.8 billion the previous year. The deterioration continued in the first quarter of 2026: income plummeted by 94%, after the foreign business stopped consolidating its results.
A conflict still open. The lawsuit does not close the battle for Nexperia, rather it prolongs it in another area. SCMP points out that Beijing and The Hague have defended that the case should be resolved “between the two companies without government interference,” as explained on April 17 by the Dutch Minister of Economy, Heleen Herbert, after meeting with the Chinese ambassador to the Netherlands, Shen Bo. The message seeks to limit the conflict, but the evolution of the case itself shows how difficult it is to separate business, courts and industrial policy when a semiconductor company is caught in the middle of the fight between China and Europe.
Images | Nexperia
GIPHY App Key not set. Please check settings